Learn more about whether Clover Health Investments, Corp. or Option Care Health, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B: King of Prussia, Pennsylvania Monday ...

The SCIg market is growing rapidly, with KORU Medical Systems outperforming competitors by capturing market share. Read why I ...

New Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

Systems (Nasdaq:KRMD) announced today that it signed a development agreement with a global pharmaceutical company.

CSL Limited (OTC:CSLLY) and uniQure Inc (NASDAQ:QURE) announced the four-year results from the pivotal HOPE-B study ...

Tonix Pharmaceuticals has reported positive topline outcomes from its Phase I single ascending dose study of its ...

Global biotechnology leader CSL Behring (ASX:CSL; USOTC: CSLLY (OTC:CSLLY)) announced the four-year results from the HOPE-B ...

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

KORU Medical Systems, Inc. ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric ...

Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...

ADMA Biologics' growth potential with Asceniv makes it a compelling Buy. Click here to find out why ADMA stock is a Strong ...